Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriad Regulatory News (TRD)

Share Price Information for Triad (TRD)

Share Price is delayed by 15 minutes
Get Live Data
285.00    0.00 (0.00%)
Bid:
280.00
Ask:
290.00
Spread: 10.00 (3.571%)
Market Cap: £49.67m
TRD Live PriceLast checked at - London Stock Exchange

Intraday Triad Share Chart

Director/PDMR Shareholding

18 Aug 2025 14:00

RNS Number : 7615V
Triad Group Plc
18 August 2025
 

 

Legal Entity Identifier (LEI) No. 213800MDNBFVEQEN1G84

18 August 2025

 

 

Triad Group plc

("Triad" or "the Company")

 

 

Director/PDMR Shareholding and Total Voting Rights

 

 

Acquisition and sale of shares following the vesting of restricted share unit awards under the Triad Employee Share Incentive Plan

 

The Company announces that, following the vesting of 750,000 Restricted Share Units ("RSUs"), previously disclosed on 1 April 2025, all shares have now been allotted as of 14 August 2025.

The vesting of RSU awards was with respect to the ordinary shares in the capital of the Company ("Ordinary Shares") to employees, including the following persons discharging managerial responsibilities ("PDMRs") under the Triad Employee Share Incentive Plan. To satisfy the vesting RSUs, all Ordinary Shares were issued under the Company's block listing.

In March 2022, pursuant to shareholder approval at the Company's general meeting, Adrian Leer, Managing Director, was granted 60,000 RSUs, Tim Eckes, Client Services Director, was granted 60,000 RSUs and James McDonald, Finance Director and Company Secretary, was granted 60,000 RSUs. Each RSU that vested represents the right to receive one Ordinary Share. The RSUs were conditional on the satisfaction of performance conditions, which the Board has confirmed have all been successfully met.

Following the vesting of these RSU awards:

- Adrian Leer held 365,379 Ordinary Shares in the Company, representing 2.10% of the current issued share capital;

- Tim Eckes held 180,374 Ordinary Shares in the Company, representing 1.04% of the current issued share capital; and

- James McDonald held 87,600 Ordinary Shares in the Company, representing 0.50% of the current issued share capital.

Upon receipt of the Ordinary Shares the PDMRs immediately sold a number of shares to cover the transaction costs and tax liabilities, following which:

- Adrian Leer now holds a total of 332,185 Ordinary Shares in the Company, representing 1.91% of the current issued share capital;

- Tim Eckes now holds a total of 147,180 Ordinary Shares in the Company, representing 0.84% of the current issued share capital; and

- James McDonald now holds a total of 54,406 Ordinary Shares in the Company, representing 0.31% of the current issued share capital.

 

Total Voting Rights

Following the acquisition and immediate sale of Ordinary Shares and for the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, the total number of Ordinary Shares with a right to vote is 17,420,388 with no shares held in treasury.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

 

 

The Notification of Dealing Forms for the above transactions, provided in accordance with the requirements of UK MAR, may be found below.

1.

Details of PDMR / person closely associated with them ("PCA")

a)

First Name

Adrian

b)

Last Name

Leer

2.

Reasons for the notification

a)

Position / status

Managing Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Triad Group plc

b)

Legal Entity Identifier code

213800MDNBFVEQEN1G84

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary shares of £0.01 each in the capital of the Company

 

 

ISIN: GB0009035741

b)

Nature of the transaction

Acquisition of shares upon vesting of RSUs & sale of shares to cover transaction costs and tax liabilities

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Acquisition

£0.01

60,000

Sale

£2.30

33,194

d)

Aggregated information

- Aggregated acquisition

- Aggregated sales

 

60,000 - average price of £0.01

33,194 - average price of £2.30

e)

Date of the transaction

14 August 2025

f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

First Name

Tim

b)

Last Name

Eckes

2.

Reasons for the notification

a)

Position / status

Client Services Director

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Triad Group plc

b)

Legal Entity Identifier code

213800MDNBFVEQEN1G84

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary shares of £0.01 each in the capital of the Company

 

 

ISIN: GB0009035741

b)

Nature of the transaction

Acquisition of shares upon vesting of RSUs & sale of shares to cover transaction costs and tax liabilities

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Acquisition

£0.01

60,000

Sale

£2.30

33,194

d)

Aggregated information

- Aggregated acquisition

- Aggregated sale

 

60,000 - average price of £0.01

33,194 - average price of £2.30

e)

Date of the transaction

14 August 2025

f)

Place of the transaction

Outside a trading venue

 

1.

Details of PDMR / person closely associated with them ("PCA")

a)

First Name

James

b)

Last Name

McDonald

2.

Reasons for the notification

a)

Position / status

Finance Director & Company Secretary

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of the entity

Triad Group plc

b)

Legal Entity Identifier code

213800MDNBFVEQEN1G84

4.

Details of the transaction(s): section to be repeated for (i) each type of

instrument; (ii) each type of transaction; (iii) each date; and (iv) each place

where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary shares of £0.01 each in the capital of the Company

 

 

ISIN: GB0009035741

b)

Nature of the transaction

Acquisition of shares upon vesting of RSUs & sale of shares to cover transaction costs and tax liabilities

c)

 

Price(s) and volume(s)

 

 

Price(s)

Volume(s)

Acquisition

£0.01

60,000

Sale

£2.30

33,194

d)

Aggregated information

- Aggregated acquisition

- Aggregated sale

 

60,000 - average price of £0.01

33,194 - average price of £2.30

e)

Date of the transaction

14 August 2025

f)

Place of the transaction

Outside a trading venue

 

 

 

For further information, please contact:

 

Triad Group Plc

James McDonald

Finance Director and Company Secretary

01908 278 450

 

Zeus Capital Limited

Darshan Patel

Tel: 020 7614 5900

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUWAURVOUWAAR
Date   Source Headline
2nd Mar 20261:00 pmRNSDirectorate change
5th Feb 202611:00 amRNSDirector/PDMR Shareholding
27th Jan 20262:00 pmRNSDirector Dealing
20th Jan 20262:30 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:00 pmRNSTotal Voting Rights
23rd Dec 202512:00 pmRNSTotal Voting Rights
25th Nov 20257:00 amRNSHalf-year Financial Report
26th Sep 20253:00 pmRNSDirector dealings
15th Sep 202512:00 pmRNSBlock listing Review
20th Aug 20252:30 pmRNSNotification of Major Holdings
18th Aug 20252:00 pmRNSDirector/PDMR Shareholding
30th Jul 202510:30 amRNSResult of AGM
7th Jul 20253:45 pmRNSNotice of AGM and Dividend declaration
2nd Jul 202510:30 amRNSDirector/PDMR Shareholding
16th Jun 20257:00 amRNSFinal Results
1st Apr 202511:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
19th Mar 20254:00 pmRNSDirector/PDMR Shareholding
14th Mar 20252:00 pmRNSBlock listing Review
7th Nov 20247:00 amRNSHalf-year Report
5th Nov 20244:30 pmRNSCommittee changes
30th Sep 20242:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20242:00 pmRNSDirector/PDMR Shareholding
20th Sep 20242:00 pmRNSDirectorate Change
16th Sep 20242:30 pmRNSBlock listing Interim Review
5th Sep 202412:00 pmRNSHolding(s) in Company
23rd Aug 20242:00 pmRNSResult of AGM
22nd Aug 202411:00 amRNSTrading Statement
9th Aug 20243:00 pmRNSHolding(s) in Company
31st Jul 20243:00 pmRNSNotice of AGM
31st Jul 20242:00 pmRNSDirector/PDMR Shareholding
31st Jul 20242:00 pmRNSHolding(s) in Company
29th Jul 20242:00 pmRNSDirector/PDMR Shareholding
25th Jul 20242:00 pmRNSDividend and AGM declaration
25th Jul 20242:00 pmRNSTotal Voting Rights
15th Jul 202410:00 amRNSHolding(s) in Company
11th Jul 202411:45 amRNSDirector/PDMR Shareholding
10th Jul 20241:57 pmRNSHolding(s) in Company
10th Jul 20241:55 pmRNSHolding(s) in Company
10th Jul 20241:50 pmRNSHolding(s) in Company
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:30 pmRNSHolding(s) in Company
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
3rd Jul 202412:30 pmRNSDirector/PDMR Shareholding
1st Jul 20243:00 pmRNSDirectorate Change
26th Jun 20247:00 amRNSAnnual Financial Report
14th Jun 202412:00 pmRNSHolding(s) in Company
3rd Jun 202410:00 amRNSTotal Voting Rights
1st May 20245:00 pmRNSHolding(s) in Company
1st May 20245:00 pmRNSTotal Voting Rights
14th Mar 20243:00 pmRNSBlock listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.